Dr. Jenna Guthmiller’s Universal Influenza Vaccine Research
Dr. Jenna Guthmiller, an Assistant Professor at the University of Colorado Anschutz School of Medicine, has been awarded the 2022 Michelson Prizes: Next Generation grant for her research on universal influenza vaccines.
Her successful grant proposal involves mapping the preexisting human B cell repertoire within the lymph nodes of the upper and lower respiratory tract that bind and respond to next-generation influenza vaccines.
By dissecting how immunity differs within the upper and lower tract, as well as within the blood, Guthmiller’s research could optimize vaccine efficacy. The $150,000 grant is given annually to investigators 35 or younger who are focused on human immunology, vaccine discovery, and immunotherapy, and will support new discoveries while building on existing findings.
About Michelson Prizes:
The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
The 2023 Michelson Prizes will be looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. For more information about the prizes, please visit https://www.michelsonmedicalresearch.org/michelson-prizes-next-generation.